Hopes Dashed As Experimental COVID-19 drug fails in human beings

Experimental COVID-19 Drug

Posted  309 Views updated 6 months ago
Image
Image

The experimental coronavirus treatment remdesivir has failed in its first randomised clinical trial.

 

Results of the trial were released on Thursday, April 23, Manila Bulletin reports.

 

According to a draft summary that went online briefly on the website of the World Health Organization (WHO), the Chinese trial involved 237 patients, with 158 on the drug and 79 in a control group.

 

Remdesivir was stopped early in 18 patients because of side effects.

 

After three months, 13.9 percent of the patients on remdesivir had succumbed to the deadly disease compared to 12.8 percent of those in the control group. The difference is not statistically significant.

 

The WHO told the Financial Times that the draft is undergoing peer review and was published early in error.

 

In other news, two lovers that stay in different countries have devised a means of seeing each other despite border closure by Denmark and Germany over COVID-19.

 

Karsten Tüchsen Hansen is an 89-year-old retired farmer while his lover Inga Rasmussen is an 85-year-old former caterer. They both meet at the Mollehusvej border crossing to chat, joke and drink while maintaining a modicum of social distance by sitting down a yard or two apart on either side of the border.

 

Karsten, who meets his lover every day, said: “We’re here because of love. Love is the best thing in the world.” 

A vial of Remdesivir Photo credit: AFP/Ulrich Perrey Source: UGC

Image
Image

infoclear

Your reaction?

0
LOL
0
LOVED
0
PURE
0
AW
0
FUNNY
0
BAD!
0
EEW
0
OMG!
0
ANGRY
0 Comments

infoclear